Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

NCT01543100

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Rennes University Hospital Rennes, Brittany Region, France

View Trial Details

Completed

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

NCT00003490

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Cleveland Clinic Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)

NCT00985959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Fukuoka, Japan

Hiroshima, Japan

Hitachi, Japan

Isehara, Japan

View all 28 locations

View Trial Details

Completed

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

NCT00205764

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Wilhelminenspital, 1st Medical Department-center for oncology and hematology Vienna, Austria

View Trial Details

Completed

Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01168804

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Medical University Hospital Graz Graz, Austria

Hospital Elisabethinen Linz Linz, Austria

LKH Salzburg, 3rd Med. Dept. Salzburg, Austria

Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria

View Trial Details

Completed

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

NCT00205751

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Wilhelminenspital, 1st Medical Department-center for oncology and hematology Vienna, Austria

View Trial Details

Completed

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

NCT00288028

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma

NCT00722488

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Winship Cancer Institute Atlanta, Georgia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Prevention of Left Ventricular Dysfunction During Chemotherapy

NCT01110824

Conditions: Acute Myeloid Leukemia, Autologous Hematopoietic Stem Cell Transplantation, Blood Protein Disorders, +25 more
Locations: Hospital Clinic Barcelona, Catalonia, Spain

Hospital Clinic Barcelona, Catalonia, Spain

View Trial Details

Completed

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

NCT00483262

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Ann Arbor, Michigan, United States

Washington University in Saint Louis St Louis, Missouri, United States

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions